SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 149 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2018. The put-call ratio across all filers is 1.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,065,000 | +35.5% | 477,621 | +76.2% | 1.44% | +58.4% |
| Q3 2017 | $786,000 | -52.6% | 271,102 | -27.3% | 0.91% | -53.6% |
| Q2 2017 | $1,658,000 | -67.4% | 372,694 | -65.9% | 1.97% | -72.3% |
| Q1 2017 | $5,088,000 | +50.5% | 1,091,768 | +96.7% | 7.09% | +12.9% |
| Q4 2016 | $3,380,000 | +80.9% | 555,085 | +63.7% | 6.28% | +93.5% |
| Q3 2016 | $1,868,000 | +64.9% | 339,068 | +13.7% | 3.25% | +56.5% |
| Q2 2016 | $1,133,000 | -34.1% | 298,190 | -1.6% | 2.08% | -20.1% |
| Q4 2015 | $1,719,000 | +59.6% | 303,157 | +49.2% | 2.60% | +8.3% |
| Q3 2015 | $1,077,000 | – | 203,155 | – | 2.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 477,621 | $1,065,000 | 1.44% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,505,804 | $3,358,000 | 1.18% |
| Nantahala Capital Management | 7,000,000 | $15,610,000 | 0.69% |
| Hikari Power Ltd | 1,900,000 | $4,237,000 | 0.50% |
| Trellus Management Company, LLC | 112,500 | $251,000 | 0.34% |
| Cheyne Capital Management (UK) LLP | 206,500 | $462,000 | 0.20% |
| KNOTT DAVID M | 201,400 | $449,000 | 0.18% |
| Paulson & Co. | 4,000,000 | $8,920,000 | 0.17% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,041,695 | $2,323,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 318,460 | $710,000 | 0.13% |